Levetiracetam in patients with refractory epilepsy: Results of the SKATE trial in Austria, Germany and Switzerland


PURPOSE To further evaluate the safety, efficacy and optimal dose of levetiracetam (LEV) in daily clinical practice among patients with uncontrolled partial epilepsy with or without secondary generalization. METHODS In this phase IV, open-label, 16-week community-based study, 178 at least 16-year-old patients with refractory focal epilepsy were treated… (More)
DOI: 10.1016/j.seizure.2005.08.005


5 Figures and Tables

Slides referencing similar topics